Cambiar Investors’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
Cambiar Investors's LLY Position: Q1 2018 in Review
Cambiar Investors sold out of Eli Lilly (LLY) in Q1 2018, closing a stake of 2,494 shares — an estimated $211K sold.
Cambiar Investors first reported a position in LLY in Q4 2016 and held it in 5 quarters. The position peaked at $46.3M in Q1 2017. 1,333 funds tracked by Wall St. Rank hold LLY as of Q1 2018.
- Cambiar Investors reported no remaining Eli Lilly position as of Q1 2018 after selling out during the quarter.
- Cambiar Investors sold 2,494 Eli Lilly shares in Q1 2018, an estimated $211K.
- Cambiar Investors first reported a position in Eli Lilly in Q4 2016 and held it in 5 quarters.
- Cambiar Investors's Eli Lilly position peaked at $46.3M in Q1 2017.
- 1,333 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2018.
Based on Cambiar Investors's 13F filing for Q1 2018, filed 26 Apr 2018.